Insider · CIK 0001190279
Raul R Rodriguez
Files at RIGL (RIGEL PHARMACEUTICALS INC). First filing -, latest -.
In brief
Raul R Rodriguez files SEC Form 4 as CEO, president and director at RIGL (RIGEL PHARMACEUTICALS INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Raul R Rodriguez has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Feb 5, 2025 | RIGL RIGEL PHARMACEUTICALS INC | 4,400 0.03% of outstanding | $96k | Feb 5, 2025 | $104k |
| Feb 4, 2025 | RIGL RIGEL PHARMACEUTICALS INC | 4,952 0.03% of outstanding | $104k | Feb 4, 2025 | none |
Transactions
Every row this insider has filed, 14 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | RIGL RIGEL PHARMACEUTICALS INC | FTax withholding Common Stock | -2,424 | $47.50 | $115k | 273,362 | 40 d ago |
| Jun 17, 2026 | RIGL RIGEL PHARMACEUTICALS INC | AGrant or award Employee Stock Option (right to buy)derivative | +31,700 | $0.00 | $0 | 31,700 | Jun 22, 2026 |
| Jun 1, 2026 | RIGL RIGEL PHARMACEUTICALS INC | FTax withholding Common Stock | -2,424 | $29.86 | $72k | 279,593 | Jun 3, 2026 |
| Feb 17, 2026 | RIGL RIGEL PHARMACEUTICALS INC | AGrant or award Common Stock | +53,915 | $0.00 | $0 | 282,017 | Feb 19, 2026 |
| Feb 10, 2026 | RIGL RIGEL PHARMACEUTICALS INC | FTax withholding Common Stock | -7,607 | $34.62 | $263k | 228,102 | Feb 12, 2026 |
| Jan 26, 2026 | RIGL RIGEL PHARMACEUTICALS INC | MOption exercise Common Stock | +40,000 | $27.40 | $1.1M | 280,454 | Feb 4, 2026 |
| Jan 26, 2026 | RIGL RIGEL PHARMACEUTICALS INC | FTax withholding Common Stock | -35,211 | $37.00 | $1.3M | 245,243 | Feb 4, 2026 |
| Jan 26, 2026 | RIGL RIGEL PHARMACEUTICALS INC | MOption exercise Common Stock | +40,000 | $27.40 | $1.1M | 285,243 | Feb 4, 2026 |
| Jan 26, 2026 | RIGL RIGEL PHARMACEUTICALS INC | FTax withholding Common Stock | -35,424 | $37.00 | $1.3M | 249,819 | Feb 4, 2026 |
| Feb 2, 2026 | RIGL RIGEL PHARMACEUTICALS INC | FTax withholding Common Stock | -14,110 | $36.01 | $508k | 235,709 | Feb 4, 2026 |
| Jan 26, 2026 | RIGL RIGEL PHARMACEUTICALS INC | MOption exercise Employee Stock Option (right to buy)derivative | -40,000 | $0.00 | $0 | 0 | Feb 4, 2026 |
| Jan 26, 2026 | RIGL RIGEL PHARMACEUTICALS INC | MOption exercise Employee Stock Option (right to buy)derivative | -40,000 | $0.00 | $0 | 0 | Feb 4, 2026 |
| Sep 15, 2025 | RIGL RIGEL PHARMACEUTICALS INC | AGrant or award Employee Stock Option (right to buy)derivative | +31,700 | $0.00 | $0 | 31,700 | Sep 17, 2025 |
| Nov 25, 2024 | RIGL RIGEL PHARMACEUTICALS INC | AGrant or award Employee Stock Option (right to buy)derivative | +30,000 | $0.00 | $0 | 30,000 | Nov 26, 2024 |
Questions about Raul R Rodriguez
Answered from the filings on this page, as of the latest one.
Is Raul R Rodriguez buying or selling?
Raul R Rodriguez has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Raul R Rodriguez's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Raul R Rodriguez has 0.
Where does Raul R Rodriguez file Form 4?
Raul R Rodriguez has filed Form 4 at RIGL (RIGEL PHARMACEUTICALS INC) as CEO, President. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.